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was 47.8 months; instead, the non-adjuvant patients mean DFS was 25 months. No differences on OS were seen. Four of twelve
(33%) patients are still alive.
Conclusions. Eventhough uterus limited ADS (stage I) have a relatively favourable clinical outcome, comparing with others uterine
sarcomas, the present study suggested that surgery (including pelvic and paraortic lymphadenectomy) and radiotherapy (EBRT
and/or BQT) confer a lower local failure rate than surgery alone in either ADS stage I. Optimal therapy is still unclear and this
series provides knowledge about adjuvant therapy and prognosis in ADS stage I.
http://dx.doi.org/10.1016/j.rpor.2013.03.226
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Introduction/Purpose. Metastases from endometrial carcinoma in central nervous system (CNS) are an uncommon site with
extremely poor prognosis. Low incidence is observed (0.3–0.9% among all endometrial carcinomas) and median time from pri-
mary diagnosis tometastases diagnosis is about 11months. Risk factors are tumoral grade (undifferentiated),miometrial invasion
depth (>50%), linfovascular invasion (LVI) and endometrioid carcinomahistology. Sintomatology consists of neurological disturbs,
such as convulsions, headache disorientation, aphasia and memory disturbs. We present a case and literature review has been
made.
Material and methods. A 76 years old woman was diagnosed from endometrial adenocarcinoma stage Ib, G3 and LVI+, after starting
with metrorragic symptoms. 2 months after primary diagnosis she presented neurological disturbs consisting in aphasia. CT
and MRI were performed and showed a single left parietal lesion, that was conﬁrmed to be a brain metastase from endometrial
adenocarcinomaby biopsy. Surgerywith complete exeresis of this lesionwas performed, and surgical intervention for the primary
tumor was made 2 months later.
Results. 2 months after brain lesion resection, hysterectomy was performed. Starting holocraneal radiotherapy as adjuvant treat-
ment, the patient presented a new convulsive crisis. Brain MRI showed a new lesion where the previous one was. The patient
entered into an epileptic non-convulsive status and died 10 days later.
Conclusions. Overall survival after brain metastases development in patients with endometrial carcinoma is poor. Combination
treatment with surgery and radiation therapy may improve survival for selected patients.
http://dx.doi.org/10.1016/j.rpor.2013.03.227
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Objective. To evaluate if radiotherapy planning with 18F-FDG PET/CT in cervical cancer (CC) can modify the gross tumor volume
(GTV) to be irradiated compared to MRI and additional diagnostic paraortic limphadenectomy. In addition, if PET/CT provides
additional information on initial staging of CC.
Materials and methods. We retrospectively analysed 12 patients with CC, who had a PET/CT scan performed for radiotherapy
planning and an MRI with an interval of time not exceeding 30 days. The GTV determined by PET/CT measure also included
subcentimetric lymph nodes with pathological 18F-FDG uptake (SUVmax>2.5).
Results. In 8/12 patients PET/CT did not induce changes in the delimitation of primary tumor and/or local spread. In 3/12 PET/CT
underestimated the GTV (MRI showed millimetric lymphadenopaties in pelvic lymph nodes suggestive of malignancy in 2
patients, while PET/CT did not reveal pathological uptake of 18F-FDG in this location, probably due to the small size of these
lymph nodes). In 2/12 PET/CT modiﬁed the nodal GTV. The PET/CT revealed pathological uptake of 18F-FDG in pelvic lymph
nodes whereas MRI did not. The PET/CT did not revealed pathological uptake of 18F-FDG in retroperitoneal lymph nodes (none
patients). In 10/12 patients diagnostic paraortic limphadenectomy was performed after the PET/TC study. The median lymph
nodes were 14.5. Only in one (1/10) it was detected positive pathologic retroperitoneal lymph node. In none patients (0%) PET/CT
detected metastases so the radio-chemotherapy treatment was no modiﬁed.
Conclusion. The combination of the information supplied by MRI and PET/TC and diagnostic paraortic limphadenectomy is useful
in the precise deﬁnition of GTV in CC., minimizing normal tissues radiation. Unknown metastases detected in PET/TC could
modify patient management in these cases.
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